ACUTE GRAFT VERSUS HOST DISEASE
Clinical trials for ACUTE GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new ACUTE GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for ACUTE GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to tame dangerous transplant complication
Disease control Recruiting nowThis trial is testing a drug called ruxolitinib as the first treatment for acute graft-versus-host disease (GVHD), a serious complication where donor cells attack the body after a bone marrow transplant. It will compare ruxolitinib alone to standard steroid treatment for lower-ri…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE2 • Sponsor: John Levine • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for stem cell transplant patients battling dangerous complication
Disease control Recruiting nowThis study is testing a new drug called gecacitinib, combined with standard steroid treatment, for patients who develop a severe immune reaction called acute graft-versus-host disease after a stem cell transplant. The trial aims to find the safest and most effective dose and see …
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Could a simple clock change reduce deadly transplant complications?
Disease control Recruiting nowThis study is testing if the time of day a patient receives a cord blood stem cell transplant affects their risk of developing a serious complication called acute graft-versus-host disease (GVHD). It will enroll 134 patients with blood cancers who are in remission and scheduled f…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE3 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for transplant patients battling severe immune reaction
Disease control Recruiting nowThis early-stage trial is testing a new oral medication called AC-003 for patients with a severe immune system complication called acute graft-versus-host disease (aGVHD) that can occur after a stem cell transplant. The study aims to find a safe dose and see if the drug can help …
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE1 • Sponsor: Accro Bioscience (Suzhou) Limited • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Can exercise fight steroid side effects for transplant patients?
Symptom relief Recruiting nowThis study is testing if a home-based exercise program can help patients who develop Graft-Versus-Host Disease (GVHD) after a stem cell transplant. The goal is to see if exercise can improve blood sugar control, body composition, fitness, and quality of life while patients are on…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Mar 20, 2026 14:48 UTC